Together to cast the peak
Release time:
2020-08-14
Work Together to Create Spike
Speaker: Spike Pharmaceutical Sales Company Zhou Yanqiu
Dear Leader, Dear Colleagues:
Hello!
I come from Jinhua Office of Jianfeng Pharmaceutical Sales Department. Our office has 8 people, a wise and funny Xia manager, a mature and stable Chen Jinying, a crisp Zheng Jie, a ghostly Lou Jing, a lively and cheerful Shao Junli, a delicate and restrained Xu Zihan, a sunny and handsome Chen Yanguo, and a heavyweight figure is just me next Zhou Yanqiu.
Although there are few people in our office, our hearts are united. Our manager Xia, like a brother, leads our small team and makes concerted efforts to move forward. Every two weeks we have a party, we talk about the family, talk about the difficulties encountered in the work, discuss the solution, in the discussion, I found that my colleagues are very wise, no matter what the problem, they can find a solution. I found that my thinking is changing and my methods are adjusting. I believe more and more that methods are always more difficult than difficulties. This is a valuable asset given to me by my team.
I remember last year's 9 9 , when the sun was blazing, I took a corn and walked around the street to eat popcorn directly. In such hot weather, I drove the customer back to Jinhua from Hangzhou. On the way, the car broke down and had to stop at the side of the road. What should I do? The customer didn't have time to send back to Jinhua. On such a hot day, people standing on the side of the road would be burnt. What if the customer had heatstroke? I stomped my feet in a hurry when I couldn't reach the village or shop. When manager Xia learned of the situation, he told me not to worry and to pick us up from Jinhua immediately and let me contact the trailer. Colleagues called one after another to comfort me. Some reminded me to turn on the double jump, some told me to pay attention to safety, and some told me not to suffer heatstroke. The comforting words at the beginning of the phone made my restless heart settle down slowly. I clearly felt their sincere feelings. I know that I am not alone in the face of difficulties at this moment. There are a group of people around me. This matter is very common, but deeply imprinted in my heart. I believe that every department of our peak has small and beautiful stories like this.
If our office is a small family, then Jianfeng Group is a big family. A drop of water will never dry up only when it is put into the sea. A person can be most powerful only when he integrates himself with the collective cause. In the big family of spike, brothers and sisters from all over the world work together. We firmly believe that work is happy and sweating like rain, which is the fruit of summer labor.
Our Jianfeng Group started from cement. After 60 years of development, it has now become a key enterprise with strong economic strength and strong technical strength in the country. What makes the peak development so rapid? I think it is our spirit of enterprise, especially "unity and struggle". Every peak person has a strong sense of honor and responsibility. As long as colleagues encounter difficulties in the company, whether it is the enterprise or brothers and sisters, everyone will lend a helping hand and care for each other like family members. Not to mention the group's annual condolences and subsidies to employees in difficulty and visits to sick employees. As the saying goes, the hearts of the people, Taishan move, in order to bring everyone together, outdoor expansion, sports meeting, orientation, calligraphy and painting, photography competition ...... In a time of activities, we increased mutual understanding, enhance the friendship between each other.
This year marks the 39th anniversary of Peak Venture 60# and the 41st anniversary of the establishment of our pharmaceutical company 20. In this 20 years, Jianfeng Pharmaceutical has been rated as one of the top 100 pharmaceutical enterprises in the country, one of the top 10 pharmaceutical enterprises in Zhejiang Province, one of the key high-tech enterprises in the National Torch Plan, and has a provincial new drug research and development center.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page